Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

NSABP B-43 is the first prospective, randomized phase III multi-institution clinical trial targeting high-risk, HER2-positive DCIS. It compares whole breast irradiation alone with WBI given concurrently with trastuzumab in women with HER2-positive DCIS treated by lumpectomy. The primary aim is to de...

全面介紹

Na minha lista:
書目詳細資料
發表在:Breast Cancer Res Treat
Main Authors: Siziopikou, Kalliopi P., Anderson, Stewart J., Cobleigh, Melody A., Julian, Thomas B., Arthur, Douglas W., Zheng, Ping, Mamounas, Eleftherios P., Pajon, Eduardo R., Behrens, Robert J., Eakle, Janice F., Leasure, Nick C., Atkins, James N., Polikoff, Jonathan A., Seay, Thomas E., McCaskill-Stevens, Worta J., Rabinovitch, Rachel, Costantino, Joseph P., Wolmark, Norman
格式: Artigo
語言:Inglês
出版: 2013
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962781/
https://ncbi.nlm.nih.gov/pubmed/24202240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2755-z
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍